Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients

NCT00338039 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Cetuximab
DRUG: Gemcitabine
DRUG: Oxaliplatin
DRUG: Capecitabine
RADIATION: Radiotherapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]